Navigation Links
Some Kids Respond Better to ADHD Drug Than Others
Date:10/23/2011

FRIDAY, Oct. 21 (HealthDay News) -- Children with specific gene variants respond better to the drug methylphenidate (Ritalin, Concerta), which is widely used to treat attention-deficit hyperactivity disorder (ADHD), a new study says.

The finding could help improve treatment of ADHD, according to the Cincinnati Children's Hospital Medical Center researchers.

"Physicians don't have a good way of predicting who will experience great improvement in ADHD symptoms with a particular medication, so currently we use a trial-and-error approach. Unfortunately, as a result, finding an effective treatment can take a long time," lead investigator Dr. Tanya Froehlich, a physician in the division of developmental and behavioral pediatrics, said in a medical center news release.

"With more information about genes that may be involved in ADHD medication response, we may be able to predict treatment course, tailor our approach to each child, and improve symptom response while decreasing health care costs," she said.

The researchers tested 89 children aged 7 to 11 with ADHD and found that those with specific variants of the dopamine transporter (DAT) and dopamine receptor D4 (DRD4) genes showed greater improvement in hyperactivity and impulsivity after taking methylphenidate than those without the gene variants.

Specifically, children with the DAT 10-repeat variant and the DRD4 gene 4-repeat showed more response to methylphenidate than those without the variants. A repeat is a short nucleotide coding sequence in a gene that's repeated.

The study was published Oct. 21 in the Journal of the American Academy of Child and Adolescent Psychiatry.

Further research in a larger number of patients is needed to confirm these findings and their clinical significance, the researchers said.

More information

The U.S. National Institute of Mental Health has more about attention deficit hyperactivity disorder.

-- Robert Preidt

SOURCE: Cincinnati Children's Hospital Medical Center, news release, Oct. 17, 2011


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. For Valentine's Day, Lifestyle Correspondent and Her Two Sets of Twins Show a Little Love Where Its Needed the Most
2. FriendsofWater.com Responds to the National Acadamy of Sciences Report that Millions of Americans Get Sick Yearly from Contaminated Water
3. American Red Cross Responds Internationally and at Home to Chile Quake
4. AUA Responds to American Cancer Society Guideline for the Early Detection of Prostate Cancer
5. AUA Foundation Responds to American Cancer Society Guideline for the Early Detection of Prostate Cancer
6. Airway Injury Plaguing 9/11 First Responders
7. Critical Recommendations Unveiled to Respond to National Public Health Crisis: Deep-Vein Thrombosis and Pulmonary Embolism
8. Tumors may respond to extreme and moderate heat
9. Critical Recommendations Unveiled to Respond to National Public Health Crisis: Deep-Vein Thrombosis and Pulmonary Embolism
10. Many WTC Responders Show Signs of Heart Trouble
11. Astellas Responds to OSI Pharmaceuticals Rejection
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2017)... New York (PRWEB) , ... May 23, 2017 ... ... NextGen LifeLabs, a leading equipment provider in the modern ART laboratory, to provide ... Institute in Ft. Lauderdale, Florida. , NextGen LifeLabs, a MedTech Group Purchasing ...
(Date:5/23/2017)... MA (PRWEB) , ... May 23, 2017 , ... Orbita’s ... on Tuesday, May 23, 2017 in San Francisco. Titled Connected Health and IoT: ... Connected Home Event hosted by Parks Associates, a market research and consulting firm ...
(Date:5/23/2017)... San Francisco, California (PRWEB) , ... May 23, 2017 , ... ... released results of its new survey in an infographic on the current state of ... 900 U.S. respondents, familiar with anxiety, was conducted in April 2017 and benchmarked general ...
(Date:5/22/2017)... Kisco, NY (PRWEB) , ... May 22, 2017 , ... ... are urged to receive relaxing sedation dentistry in Mt. Kisco, NY from Advanced Endodontics ... be administered for a variety of treatments. One or more sedation methods may be ...
(Date:5/22/2017)... ... May 22, 2017 , ... An inventor from Columbia, S.C., ... pen. "My wife’s hand was damaged in a firework accident, so she couldn’t grip ... with manual problems." , He then designed and created a prototype for the HELPEN ...
Breaking Medicine News(10 mins):
(Date:5/15/2017)... PHILADELPHIA , May 15, 2017 Enterin Inc., ... and developing novel compounds to treat Parkinson,s disease ... The study is a Phase 1/2a randomized, controlled, multicenter study ... sites. It will enroll 50 patients over a 9-to-12-month period. ... doses in 10 patients with PD. Participating sites include ...
(Date:5/10/2017)...  The Corporate Whistleblower Center says, "We are ... clinics to call us anytime at 866-714-6466 if they ... in a substantial scheme to overbill Medicare. We ... employee of a medical equipment company if their ... medical practice groups with extra generous incentives to use, ...
(Date:5/9/2017)... , May 9, 2017  Oramed Pharmaceuticals Inc. ... a clinical-stage pharmaceutical company focused on the development ... the Canadian Intellectual Property Office has granted Oramed ... Administration of Exenatide". The patent covers Oramed,s invention ... GLP-1 is an incretin hormone that stimulates ...
Breaking Medicine Technology: